Clinical trial

Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial

NCT03699904

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-10-11

PhasePHASE2

Study timeline

Study start (actual)2018-10-11Date precision: day

Registry last updated2020-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

EBVunresolved

Interventions

ValaciclovirDRUG

Placebo capsules (containing Avicel blend)DRUG

Sponsors & collaborators

Belfast Health and Social Care Trustlead sponsor

Northern Ireland Clinical Trials Unitcollaborator

Queen's University, Belfastcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03699904 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.